Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.
Published November 8, 2017 · Recall initiated: October 6, 2017
Summary
FDA records drug Class II recall D-0055-2018, published November 8, 2017 and initiated October 6, 2017. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 274 cartons; Lot: Lot: 18103 Exp. 11/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AVKARE Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lot: 18103 Exp. 11/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TNAugust 17, 2022
- FDAPhytonadione Tablets 5 mg, Rx Only, 30 Tablets (3x10) Unit Dose, Manufactured for: AvKARE Pulaski, TN 38478.June 23, 2021
- FDASildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDCDecember 23, 2020
- FDATraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TNDecember 23, 2020
- FDAClofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5,November 8, 2017
- FDAOncentra Brachy 4.5 radiation therapy software The firm name on the label is Nucletron B.V. Oncentra is aNovember 1, 2017
Questions about this recall
Was Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15. recalled?
Yes. FDA published recall D-0055-2018 on November 8, 2017. Reported hazard: Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
What should I do if I have this product?
Voluntary: Firm initiated · Letter